Collins, Natalie B.
Broad Institute · Boston Children's Hospital · Dana-Farber Cancer Institute · Massachusetts Institute of Technology
2 papers on CoChatORCID 0000-0003-2980-9244
Most cited papers
- Verified
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,147
- Verified
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature
Cancer Immunotherapy and BiomarkersRNA regulation and disease
Cited by 697
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free